Exosome-guided bone targeted delivery of Antagomir-188 as an anabolic therapy for bone loss

Zhou, 2014, Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow, Cell Stem Cell, 15, 154, 10.1016/j.stem.2014.06.008 Ambrosi, 2017, Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration, Cell Stem Cell, 20, 771, 10.1016/j.stem.2017.02.009 Zou, 2020, Ablation of fat cells in adult mice induces massive bone gain, Cell Metabol., 32, 801, 10.1016/j.cmet.2020.09.011 Wu, 2020, Enhanced osteogenesis and therapy of osteoporosis using simvastatin loaded hybrid system, Bioactive materials, 5, 348, 10.1016/j.bioactmat.2020.03.004 Metavarayuth, 2019, Nanotopographical cues mediate osteogenesis of stem cells on virus substrates through BMP-2 intermediate, Nano Lett., 19, 8372, 10.1021/acs.nanolett.9b02001 Shang, 2021, Advancing application of mesenchymal stem cell-based bone tissue regeneration, Bioactive materials, 6, 666, 10.1016/j.bioactmat.2020.08.014 Li, 2020, Targeting actin-bundling protein L-plastin as an anabolic therapy for bone loss, Sci Adv, 6, eabb7135, 10.1126/sciadv.abb7135 Chen, 2018, RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation, Bone research, 6, 34, 10.1038/s41413-018-0035-6 Wang, 2020, New insight into unexpected bone formation by denosumab, Drug Discov. Today, 20, 30340 Frith, 2018, Mechanically-sensitive miRNAs bias human mesenchymal stem cell fate via mTOR signalling, Nat. Commun., 9, 257, 10.1038/s41467-017-02486-0 Li, 2015, miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway, Cell Death Differ., 22, 1935, 10.1038/cdd.2015.99 Li, 2015, MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation, J. Clin. Invest., 125, 1509, 10.1172/JCI77716 Pecot, 2014, Therapeutic silencing of KRAS using systemically delivered siRNAs, Mol. Canc. Therapeut., 13, 2876, 10.1158/1535-7163.MCT-14-0074 Yuan, 2014, Development of siRNA payloads to target KRAS-mutant cancer, Canc. Discov., 4, 1182, 10.1158/2159-8290.CD-13-0900 Xue, 2014, Small RNA combination therapy for lung cancer, P Nat Acad Sci USA, 111, E3553, 10.1073/pnas.1412686111 Itaka, 2007, Bone regeneration by regulated in vivo gene transfer using biocompatible polyplex nanomicelles, Mol. Ther. : the journal of the American Society of Gene Therapy, 15, 1655, 10.1038/sj.mt.6300218 Zhang, 2012, A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy, Nat. Med., 18, 307, 10.1038/nm.2617 Liang, 2015, Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy, Nat. Med., 21, 288, 10.1038/nm.3791 Wang, 2016, Nanomaterials promise better bone repair, Mater. Today, 19, 451, 10.1016/j.mattod.2015.12.003 Kalluri, 2020, The biology, function, and biomedical applications of exosomes, Science, 367, 10.1126/science.aau6977 Elsharkasy, 2020, Extracellular vesicles as drug delivery systems: why and how?, Adv. Drug Deliv. Rev., 159, 332, 10.1016/j.addr.2020.04.004 Perets, 2019, Golden exosomes selectively target brain pathologies in neurodegenerative and neurodevelopmental disorders, Nano Lett., 19, 3422, 10.1021/acs.nanolett.8b04148 Quinn, 2021, Conferring receptors on recipient cells with extracellular vesicles for targeted drug delivery, Bioactive materials, 6, 749, 10.1016/j.bioactmat.2020.09.016 Nie, 2020, Responsive exosome nano-bioconjugates for synergistic cancer therapy, Angew Chem. Int. Ed. Engl., 59, 2018, 10.1002/anie.201912524 Kamerkar, 2017, Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer, Nature, 546, 498, 10.1038/nature22341 Lin, 2018, Exosome-liposome hybrid nanoparticles deliver CRISPR/Cas9 system in MSCs, Adv. Sci., 5, 10.1002/advs.201700611 Geminder, 2001, A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma, J. Immunol., 167, 4747, 10.4049/jimmunol.167.8.4747 Zehentmeier, 2019, Cell circuits and niches controlling B cell development, Immunol. Rev., 289, 142, 10.1111/imr.12749 Smit, 2020, The CXCL12/CXCR4/ACKR3 Axis in the tumor microenvironment: signaling, crosstalk, and therapeutic targeting, Annu. Rev. Pharmacol. Toxicol., 61, 541, 10.1146/annurev-pharmtox-010919-023340 Conley-LaComb, 2016, Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis, Mol. Canc., 15, 68, 10.1186/s12943-016-0552-0 Muller, 2001, Involvement of chemokine receptors in breast cancer metastasis, Nature, 410, 50, 10.1038/35065016 Song, 2019, Reversal of osteoporotic activity by endothelial cell-secreted bone targeting and biocompatible exosomes, Nano Lett., 19, 3040, 10.1021/acs.nanolett.9b00287 Stewart, 2016, In vitro and ex vivo strategies for intracellular delivery, Nature, 538, 183, 10.1038/nature19764 Peled, 1999, Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4, Science, 283, 845, 10.1126/science.283.5403.845 Morrison, 2014, The bone marrow niche for haematopoietic stem cells, Nature, 505, 327, 10.1038/nature12984 Jin, 2006, Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes, Nat. Med., 12, 557, 10.1038/nm1400 Teicher, 2010, CXCL12 (SDF-1)/CXCR4 pathway in cancer, Clin. Canc. Res., 16,, 2927, 10.1158/1078-0432.CCR-09-2329 Huang, 2018, Neutralizing negative epigenetic regulation by HDAC5 enhances human haematopoietic stem cell homing and engraftment, Nat. Commun., 9, 2741, 10.1038/s41467-018-05178-5 Staller, 2003, Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL, Nature, 425, 307, 10.1038/nature01874 Muller, 2001, Involvement of chemokine receptors in breast cancer metastasis, Nature, 410, 50, 10.1038/35065016 El-Andaloussi, 2012, Exosome-mediated delivery of siRNA in vitro and in vivo, Nat. Protoc., 7, 2112, 10.1038/nprot.2012.131 Yang, 2020, Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation, Nat Biomed Eng, 4, 69, 10.1038/s41551-019-0485-1 Pedroso, 2001, Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications, Adv. Drug Deliv. Rev., 47, 277, 10.1016/S0169-409X(01)00110-7 Zhang, 2019, Targeted codelivery of an antigen and dual agonists by hybrid nanoparticles for enhanced cancer immunotherapy, Nano Lett., 19, 4237, 10.1021/acs.nanolett.9b00030 Lv, 2020, Thermosensitive exosome-liposome hybrid nanoparticle-mediated chemoimmunotherapy for improved treatment of metastatic peritoneal cancer, Adv. Sci., 7, 10.1002/advs.202000515 Piffoux, 2018, Modification of extracellular vesicles by fusion with liposomes for the design of personalized biogenic drug delivery systems, ACS Nano, 12, 6830, 10.1021/acsnano.8b02053 Bala, 2015, Role of cortical bone in bone fragility, Curr. Opin. Rheumatol., 27, 406, 10.1097/BOR.0000000000000183 Cooper, 2016, Cortical bone porosity: what is it, why is it important, and how can we detect it?, Curr. Osteoporos. Rep., 14, 187, 10.1007/s11914-016-0319-y Tsai, 2016, Effects of two years of teriparatide, denosumab, or both on bone microarchitecture and strength (DATA-HRpQCT study), J. Clin. Endocrinol. Metabol., 101, 2023, 10.1210/jc.2016-1160 Tsai, 2017, Effects of denosumab and teriparatide transitions on bone microarchitecture and estimated strength: the DATA-switch HR-pQCT study, J. Bone Miner. Res., 32, 2001, 10.1002/jbmr.3198